CALCITRIOL KP calcitriol 0.25 microgram capsule blister pack

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

calcitriol, Quantity: 0.25 microgram

Disponible depuis:

Amneal Pharma Australia Pty Ltd

DCI (Dénomination commune internationale):

Calcitriol

forme pharmaceutique:

Capsule, soft

Composition:

Excipient Ingredients: fractionated coconut oil; butylated hydroxyanisole; butylated hydroxytoluene; Gelatin; glycerol; sorbitol solution (70 per cent) (non-crystallising); purified water; iron oxide red; iron oxide yellow; titanium dioxide

Mode d'administration:

Oral

Unités en paquet:

100 capsules

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

Calcitriol KP is indicated for the treatment of established osteoporosis diagnosed by objective measuring techniques, such as densitometry, or by radiographic evidence of atraumatic fracture.,Calcitriol KP is also indicated for the prevention of corticosteroid-induced osteoporosis in patients commencing oral steroid therapy in a dose and regimen expected to result in a significant bone loss.,Calcitriol KP is indicated in the treatment of hypocalcemia in patients with uremic osteodystrophy, hypoparathyroidism and in hypophosphataemic rickets.

Descriptif du produit:

Visual Identification: Red coloured, oval soft gelatin capsules containing a clear oily liquid.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Statut de autorisation:

Licence status A

Date de l'autorisation:

2015-12-01